
Medical Device Manufacturer


The 8th China International Import Expo

Visit to Open New Horizons, Cooperation for Mutual Benefits




From November 5 to 10, 2025, the eighth China International Import Expo will be grandly held in Shanghai. At this year's CIIE, the Medical Devices and Healthcare Products Exhibition Area continues with the theme of "Healthy China, Better Life," showcasing internationally leading medical innovations, cutting-edge technologies, and services.
China National Medical Device Co., Ltd. (hereinafter referred to as "CNMD"), a subsidiary of China National Pharmaceutical Group Corporation, has participated in the CIIE-related activities for eight consecutive years. From precise对接 during collective tours to fruitful centralized signings, CNMD has fulfilled its commitment to openness through diverse participation and demonstrated the CIIE theme of "Openness Creates New Opportunities, Cooperation Shares a New Future" via in-depth collaboration. CNMD contributes its solutions to enhance the resilience of the global medical device industry chain and supply chain, injecting Chinese strength.


On the morning of November 7, Hu Jianwei, head of the China National Pharmaceutical Group Corporation (Sinopharm) trading delegation and Sinopharm's Vice General Manager, led a team to visit the medical device and healthcare exhibition area. They visited booths of key partners of Sinopharm’s medical device division, including Terumo, GE Healthcare, Johnson & Johnson Medical Technology, Edwards, Medtronic, Siemens, BD, Philips, Intuitive Fosun, and Wan Yite. The group engaged in in-depth discussions on cutting-edge technology, high-end equipment, and precision medicine, jointly exploring new directions and opportunities for collaboration.

During the CIIE, China National Medical Device Co., Ltd. and its subsidiaries signed tentative purchase agreements with 10 globally leading medical device companies, including Medtronic, Johnson & Johnson Medical Technology, GE Healthcare, Terumo, B. Braun, LivaNova, WanYiTe, Bayer, Edwards Lifesciences, and Agilent, demonstrating their sincere intention to cooperate with global trading partners through concrete actions. The signing was witnessed by leaders and guests, including Hu Jianwei.

Through eight years of dedication and deep cultivation, China National Medical Device Co., Ltd. has not only achieved win-win development at the CIIE but also established a long-term and stable international cooperation platform with global industry partners. In the future, the company will continue to use the CIIE as a link, actively fulfill its responsibilities as a central enterprise in China's opening-up strategy, deepen international cooperation, expand new development opportunities, write a new chapter of openness, and contribute central enterprise strength to advancing the Healthy China initiative and improving people’s livelihood.




Source: China National Medical Device Co., Ltd.